Syverson Strege & Co’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39M | Buy |
1,789
+1,352
| +309% | +$1.05M | 0.33% | 33 |
|
|
2025
Q1 | $361K | Buy |
437
+22
| +5% | +$18.2K | 0.12% | 56 |
|
|
2024
Q4 | $320K | Buy |
+415
| New | +$320K | 0.11% | 57 |
|
|
2024
Q3 | – | Sell |
-473
| Closed | -$428K | – | 73 |
|
|
2024
Q2 | $428K | Buy |
473
+136
| +40% | +$123K | 0.15% | 47 |
|
|
2024
Q1 | $262K | Buy |
+337
| New | +$262K | 0.09% | 59 |
|
|
2023
Q2 | – | Sell |
-414
| Closed | -$142K | – | 376 |
|
|
2023
Q1 | $142K | Buy |
414
+84
| +25% | +$28.8K | 0.06% | 72 |
|
|
2022
Q4 | $121K | Hold |
330
| – | – | 0.05% | 82 |
|
|
2022
Q3 | $107K | Hold |
330
| – | – | 0.05% | 85 |
|
|
2022
Q2 | $107K | Hold |
330
| – | – | 0.04% | 98 |
|
|
2022
Q1 | $95K | Hold |
330
| – | – | 0.1% | 92 |
|
|
2021
Q4 | $91K | Sell |
330
-120
| -27% | -$33.1K | 0.07% | 100 |
|
|
2021
Q3 | $104K | Buy |
450
+120
| +36% | +$27.7K | 0.08% | 96 |
|
|
2021
Q2 | $76K | Hold |
330
| – | – | 0.07% | 103 |
|
|
2021
Q1 | $62K | Hold |
330
| – | – | 0.06% | 106 |
|
|
2020
Q4 | $56K | Buy |
+330
| New | +$56K | 0.05% | 106 |
|